Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insulet Corporation

https://www.insulet.com/

Latest From Insulet Corporation

Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with industry leaders in medtech and healthtech and demos of some of the most innovative tech seen at CES 2024 in Las Vegas. Hannah Daniel dives into the latest developments in the intellectual property dispute between Apple and Masimo over blood oxygen sensors in the newer Apple Watch models.

Digital Health Artificial Intelligence

Medtronic Is Not Going With The EOFlow – Deal Cancelled

Medtronic is dropping plans to acquire EOFlow, which has faced numerous patent lawsuits from Insulet.

M & A Diabetic Care

No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype

Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned. 

Diabetic Care Drug Delivery Technology

Senseonics See Few Barriers To Adoption For Their Implantable CGM

GLP-1 inhibitors and an ever-shrinking company ecosystem are not issues for the company, according to its CEO.

Diabetic Care Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • Insulet Canada Corporation
    • Neighborhood Diabetes
    • Neighborhood Holdings, Inc.
UsernamePublicRestriction

Register